{
  "trial_id": "NCT00463450",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Written informed consent",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Postmenopausal status (amenorrhea for at least 12 months)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "45 - 65 years of age",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Application of estrogen or cyclic estrogen/progestin preparation other than the study",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "medication for at least 6 months prior to Visit 1",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Uterine bleeding of unknown etiology within the last 2 years",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Previous or existing or suspected carcinoma of the breast",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "The patient has Hashimoto disease, but it does not seem to be a contraindication for this trial. However, her high TSH levels and low free T4 levels may require further evaluation.",
  "_meta": {
    "topic_id": "66",
    "trial_id": "NCT00463450",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}